(Q45013859)

English

The Kaposi's sarcoma-associated herpesvirus complement control protein mimics human molecular mechanisms for inhibition of the complement system

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

The Kaposi's sarcoma-associated herpesvirus complement control protein mimics human molecular mechanisms for inhibition of the complement system (English)

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

7

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

David J. Blackbourn

object named as

David J Blackbourn

5

0 references

Bruno O Villoutreix

object named as

Bruno O Villoutreix

6

0 references

author name string

Linda Mark

1

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

O Brad Spiller

3

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

David Proctor

4

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

language of work or name

0 references

publication date

10 August 2004

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

number of pages

9

1 reference

based on heuristic

inferred from page(s)

Journal of Biological Chemistry

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

279

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

43

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

45093-45101

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M407558200

21 January 2018

Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M407558200

21 January 2018

Nucleotide sequence of the Kaposi sarcoma-associated herpesvirus (HHV8)

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M407558200

21 January 2018

Kaposi's sarcoma-associated herpesvirus latent and lytic gene expression as revealed by DNA arrays

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M407558200

21 January 2018

Complement regulation by Kaposi's sarcoma-associated herpesvirus ORF4 protein.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M407558200

21 January 2018

Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) open reading frame 4 protein (kaposica) is a functional homolog of complement control proteins

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M407558200

21 January 2018

Inhibition of the complement cascade by the major secretory protein of vaccinia virus

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M407558200

21 January 2018

Variola virus immune evasion design: expression of a highly efficient inhibitor of human complement

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M407558200

21 January 2018

The relevance of complement to virus biology

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M407558200

21 January 2018

Vaccinia virus complement-control protein prevents antibody-dependent complement-enhanced neutralization of infectivity and contributes to virulence

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M407558200

21 January 2018

In vivo role of complement-interacting domains of herpes simplex virus type 1 glycoprotein gC

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M407558200

21 January 2018

Critical role of complement and viral evasion of complement in acute, persistent, and latent gamma-herpesvirus infection

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M407558200

21 January 2018

Mutations in alpha-chain of C4BP that selectively affect its factor I cofactor function

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M407558200

21 January 2018

Three-dimensional structure of a complement control protein module in solution

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M407558200

21 January 2018

Mapping of regions within the vaccinia virus complement control protein involved in dose-dependent binding to key complement components and heparin using surface plasmon resonance

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M407558200

21 January 2018

Restoration of complement-enhanced neutralization of vaccinia virus virions by novel monoclonal antibodies raised against the vaccinia virus complement control protein

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M407558200

21 January 2018

Crystal structure of a complement control protein that regulates both pathways of complement activation and binds heparan sulfate proteoglycans

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M407558200

21 January 2018

The interpretation of protein structures: Estimation of static accessibility

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M407558200

21 January 2018

Structural investigation of C4b-binding protein by molecular modeling: localization of putative binding sites.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M407558200

21 January 2018

Human and rodent decay-accelerating factors (CD55) are not species restricted in their complement-inhibiting activities

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M407558200

21 January 2018

Purification of the human complement control protein C3b inactivator

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M407558200

21 January 2018

The unactivated form of the first component of human complement, C1

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M407558200

21 January 2018

Degradation of human complement component C4b in the presence of the C4b-binding protein-protein S complex

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M407558200

21 January 2018

Mapping CD55 function. The structure of two pathogen-binding domains at 1.7 A

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M407558200

21 January 2018

Characterization of the active sites in decay-accelerating factor

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M407558200

21 January 2018

Complement regulation at the molecular level: The structure of decay-accelerating factor

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M407558200

21 January 2018

A Corresponding Tyrosine Residue in the C2/Factor B Type A Domain Is a Hot Spot in the Decay Acceleration of the Complement C3 Convertases

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M407558200

21 January 2018

Structure/function studies of human decay-accelerating factor

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M407558200

21 January 2018

Structural requirements for the complement regulatory activities of C4BP.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M407558200

21 January 2018

Diversity of sites for measles virus binding and for inactivation of complement C3b and C4b on membrane cofactor protein CD46.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M407558200

21 January 2018

CCP1-4 of the C4b-binding protein alpha-chain are required for factor I mediated cleavage of complement factor C3b.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M407558200

21 January 2018

Structure of the C3b binding site of CR1 (CD35), the immune adherence receptor

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M407558200

21 January 2018

A cluster of positively charged amino acids in the C4BP alpha-chain is crucial for C4b binding and factor I cofactor function

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M407558200

21 January 2018

Positively charged amino acids at the interface between alpha-chain CCP1 and CCP2 of C4BP are required for regulation of the classical C3-convertase.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M407558200

21 January 2018

Dissecting Sites Important for Complement Regulatory Activity in Membrane Cofactor Protein (MCP; CD46)

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M407558200

21 January 2018

Identifiers

10.1074/JBC.M407558200

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45013859&oldid=2062339645"